ANCO’s ASCO Highlights 2019

 

ANCO’s ASCO Highlights 2019
H

ANCO's ASCO Update on Breast Cancer - Margetuximab + Chemo Improves PFS in HER2+ Breast Cancer & OS Benefit of Adding Atezolizumab to Nab-Paclitaxel in TNBC

By ANCO’s ASCO Highlights 2019 FEATURING Helen K. Chew
By ANCO’s ASCO Highlights 2019 FEATURING Helen K. Chew
0 views
September 12, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Breast
15:19
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update on HR+ Breast Cancer - Increased OS with Rib…

Feat. H. Chew
12:02
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update on Breast Cancer - Margetuximab + Chemo Impr…

Feat. H. Chew